Cargando…
Fluorodeoxyglucose positron emission tomography and chemotherapy-related tumor marker expression in non-small cell lung cancer
BACKGROUND: The chemotherapy resistance of non-small cell lung cancer (NSCLC) remains a clinic challenge and is closely associated with several biomarkers including epidermal growth factor receptor (EGFR) ( Drugs 72(Suppl 1):28–36, 012.), p53 ( Med Sci Monit 11(6):HY11–HY20, 2005.) and excision repa...
Autores principales: | Duan, Xiao-Yi, Wang, Wen, Wang, Jian-Sheng, Shang, Jin, Gao, Jun-Gang, Guo, You-Min |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3835621/ https://www.ncbi.nlm.nih.gov/pubmed/24237755 http://dx.doi.org/10.1186/1471-2407-13-546 |
Ejemplares similares
-
Adaptive Fluorodeoxyglucose-Positron Emission Tomography Based Chemotherapy Selection for Metastatic Non-small Cell Lung Cancer
por: Eaton, Keith D, et al.
Publicado: (2021) -
Fluorodeoxyglucose Positron Emission Tomography–Computed Tomography in Disseminated Cryptococcosis
por: Tripathy, Sarthak, et al.
Publicado: (2017) -
Positron emission tomography imaging of lung cancer: An overview of alternative positron emission tomography tracers beyond F18 fluorodeoxyglucose
por: Zhu, Jing, et al.
Publicado: (2022) -
Hepatic Pseudolymphoma with Fluorodeoxyglucose Uptake on Positron Emission Tomography
por: Suzumura, Kazuhiro, et al.
Publicado: (2017) -
Fluorodeoxyglucose positron emission tomography in pyrexia of unknown origin
por: Angamuthu, Meivel, et al.
Publicado: (2020)